In a study of 15 Chinese R/R ALL patients treated with CAR-T19, IL-6 is one of the most important biomarkers for CRS but paired peak serum levels of IL-2 levels were not associated with CRS (27). This evidence concerns the gene IL2 and acute lymphoblastic leukemia.